SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-20-000122
Filing Date
2020-11-06
Accepted
2020-11-06 16:11:48
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20200930.htm   iXBRL 10-Q 1697266
2 EX-2.5 exhibit25ligand-cvragr.htm EX-2.5 110277
3 EX-10.2 exhibit102ligandcydexg.htm EX-10.2 31196
4 EX-31.1 lgnd_93020exhibit311.htm EX-31.1 16579
5 EX-31.2 lgnd_93020exhibit312.htm EX-31.2 16918
6 EX-32.1 lgnd_93020exhibit321.htm EX-32.1 11411
12 lgnd-20200930_g1.jpg GRAPHIC 11735
  Complete submission text file 0000886163-20-000122.txt   8449432

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20200930.xsd EX-101.SCH 49928
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20200930_cal.xml EX-101.CAL 119087
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20200930_def.xml EX-101.DEF 335739
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20200930_lab.xml EX-101.LAB 704521
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20200930_pre.xml EX-101.PRE 430291
13 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20200930_htm.xml XML 1540184
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 201294533
SIC: 2834 Pharmaceutical Preparations